PL367040A1 - Związki przydatne do leczenia chorób, w których pośredniczy alfa-2B-adrenoreceptor, lub do zapobiegania tym chorobom - Google Patents
Związki przydatne do leczenia chorób, w których pośredniczy alfa-2B-adrenoreceptor, lub do zapobiegania tym chorobomInfo
- Publication number
- PL367040A1 PL367040A1 PL02367040A PL36704002A PL367040A1 PL 367040 A1 PL367040 A1 PL 367040A1 PL 02367040 A PL02367040 A PL 02367040A PL 36704002 A PL36704002 A PL 36704002A PL 367040 A1 PL367040 A1 PL 367040A1
- Authority
- PL
- Poland
- Prior art keywords
- adrenoceptor
- alpha
- prevention
- treatment
- compounds useful
- Prior art date
Links
- 102000008841 Alpha 2B adrenoceptor Human genes 0.000 title 1
- 108050000738 Alpha 2B adrenoceptor Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 230000006806 disease prevention Effects 0.000 title 1
- 230000001404 mediated effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30644901P | 2001-07-20 | 2001-07-20 | |
| FI20011560A FI116940B (fi) | 2001-07-20 | 2001-07-20 | Alfa-2B-adrenoseptorivälitteisen sairauden hoitoon tai ehkäisyyn käyttökelpoiset yhdisteet |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL367040A1 true PL367040A1 (pl) | 2005-02-21 |
Family
ID=26161203
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL02367040A PL367040A1 (pl) | 2001-07-20 | 2002-07-22 | Związki przydatne do leczenia chorób, w których pośredniczy alfa-2B-adrenoreceptor, lub do zapobiegania tym chorobom |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1417182A1 (pl) |
| JP (1) | JP2004535467A (pl) |
| CA (1) | CA2454187A1 (pl) |
| HU (1) | HUP0401076A2 (pl) |
| IL (1) | IL159511A0 (pl) |
| MX (1) | MXPA04000615A (pl) |
| NZ (1) | NZ530366A (pl) |
| PL (1) | PL367040A1 (pl) |
| RU (1) | RU2004105035A (pl) |
| WO (1) | WO2003008387A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI118265B (fi) * | 2004-01-15 | 2007-09-14 | Jurilab Ltd Oy | Menetelmä akuutin sydäninfarktin ja sepelvaltimotaudin riskin havaitsemiseksi |
| ES2401877T3 (es) | 2005-03-23 | 2013-04-25 | Klat-Pharma Animal Health Gmbh | Uso de amidas de sulfadimidina para el tratamiento de enfermedades intestinales en ciencia veterinaria |
| MA50440A (fr) | 2017-10-24 | 2020-09-02 | Bayer Ag | Imidazopyridinamides substituées et leur utilisation |
| WO2020216669A1 (de) | 2019-04-23 | 2020-10-29 | Bayer Aktiengesellschaft | Phenylsubstituierte imidazopyridinamide und ihre verwendung |
| CN116396236B (zh) * | 2023-04-19 | 2025-03-18 | 河北科技大学 | 一种二芳基甲基磺胺类化合物及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2086544C1 (ru) * | 1991-06-13 | 1997-08-10 | Хоффманн-Ля Рош АГ | Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина |
| US6150389A (en) * | 1994-07-11 | 2000-11-21 | Allergan Sales, Inc. | Comformationally rigid bicyclic and adamantane derivatives useful as α2 -adrenergic blocking agents |
| KR20020080413A (ko) * | 2000-02-11 | 2002-10-23 | 오와이 주반티아 팔마 리미티드 | 알파-2비-아르레노셉터에 의해서 매개된 질병의 치료 또는예방에 유용한 화합물 |
| PL357678A1 (pl) * | 2000-04-28 | 2004-07-26 | Sankyo Company, Limited | Modulatory PPAR |
-
2002
- 2002-07-22 WO PCT/FI2002/000643 patent/WO2003008387A1/en not_active Ceased
- 2002-07-22 RU RU2004105035/04A patent/RU2004105035A/ru not_active Application Discontinuation
- 2002-07-22 NZ NZ530366A patent/NZ530366A/en unknown
- 2002-07-22 PL PL02367040A patent/PL367040A1/pl not_active Application Discontinuation
- 2002-07-22 CA CA002454187A patent/CA2454187A1/en not_active Abandoned
- 2002-07-22 IL IL15951102A patent/IL159511A0/xx unknown
- 2002-07-22 EP EP02748902A patent/EP1417182A1/en not_active Withdrawn
- 2002-07-22 HU HU0401076A patent/HUP0401076A2/hu unknown
- 2002-07-22 MX MXPA04000615A patent/MXPA04000615A/es unknown
- 2002-07-22 JP JP2003513947A patent/JP2004535467A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CA2454187A1 (en) | 2003-01-30 |
| EP1417182A1 (en) | 2004-05-12 |
| JP2004535467A (ja) | 2004-11-25 |
| HUP0401076A2 (hu) | 2004-09-28 |
| WO2003008387A1 (en) | 2003-01-30 |
| MXPA04000615A (es) | 2004-04-20 |
| NZ530366A (en) | 2005-02-25 |
| RU2004105035A (ru) | 2005-06-27 |
| IL159511A0 (en) | 2004-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL160884A0 (en) | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease | |
| IL159344A0 (en) | Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease | |
| IL144101A0 (en) | Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin d2 | |
| AU2001282873A1 (en) | Quinuclidine-substituted aryl compounds for treatment of disease | |
| ZA200305691B (en) | The use of substituted azetidione compounds for the treatment of sitosterolemia | |
| EP1594512A4 (en) | COMPOUNDS FOR THE TREATMENT OF VIRUS INFECTIONS | |
| ZA200309627B (en) | Compounds for the treatment of metabolic disorders | |
| AU2001284645A1 (en) | Quinuclidine-substituted aryl compounds for treatment of disease | |
| IL161070A0 (en) | Compositions for the treatment of infectious diseases | |
| GB0329874D0 (en) | Compounds useful for the treatment of diseases | |
| AU2003258145A8 (en) | Substituted phenylindoles for the treatment of hiv | |
| EP1461030A4 (en) | AMINOALKYL-BENZOFURAN-5-OL COMPOUNDS FOR THE TREATMENT OF GLAUCOMA | |
| PL369402A1 (pl) | Nowe zastosowanie do leczenia choroby refluksowejprzełyku | |
| GB0124124D0 (en) | Methods of treatment | |
| IL159511A0 (en) | Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor | |
| AU2002364711A8 (en) | Substituted 5-hydroxy-indole compounds for the treatment of glaucoma | |
| GB2392838B (en) | Calcium L-threonate for preventing or treating cartilage related diseases | |
| ZA200205835B (en) | Compounds useful for the treatment or prevention of a disease mediated by the alpha-2B-adrenoceptor. | |
| EP1513550A4 (en) | NEW BACTERIUM FOR THE TREATMENT OF DISEASES | |
| IL151017A0 (en) | Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor | |
| AU2003240174A8 (en) | Compositions for the treatment of edematous-firbrosclerotic panniculopathy | |
| AU2002251202A1 (en) | Intimins for the prevention or treatment of infections: i | |
| GB0100092D0 (en) | Treatment of degenerative diseases | |
| MXPA03006468A (es) | Composiciones para la prevencion o tratamiento de hepatopatia. | |
| PL367634A1 (pl) | Kompozycja farmaceutyczna, zawierająca związek trójcykliczny, do profilaktyki i leczenia chorób skóry |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |